We help your company transform into an organization, agile and Data-Driven
The life sciences sector is a very important strategic asset for our country.
The industry is in turmoil and the market environment is changing rapidly. On the one hand, competition is getting tighter and the complexity of regulatory compliance is growing; on the other hand, the opportunities offered by topics such as digitization, Big Data or approaches that are new to the industry, such as Quality by Design, offer opportunities for growth and expansion of offerings yet to be explored. Moreover, the sector was among the last to embrace the Lean philosophy and therefore still presents very interesting opportunities to improve its margins through the acquisition of operational excellence in manufacturing, logistics and supply chain.
Bonfiglioli Consulting has many years of experience in the field and offers a structured approach to accompany companies on a path of growth:
A meeting with a practical slant where technological innovation and business strategies are integrated to bring concrete and lasting results.
Quality by Design is the modern application of Juran's concept: through constant process planning and control, the production system is able to design quality natively from the process and, thus, ensure product quality.
Italian pharmaceutical industry trends and opportunities, an overview of the market in the five-year period 2021-2026. Source: GlobalData | Content Curation: Knowledge Office Bonfiglioli Consulting
